WO2004080958A3 - Procede pour preparer des tetrahydrotriazolopyrazines et leurs produits intermediaires - Google Patents
Procede pour preparer des tetrahydrotriazolopyrazines et leurs produits intermediaires Download PDFInfo
- Publication number
- WO2004080958A3 WO2004080958A3 PCT/US2004/006429 US2004006429W WO2004080958A3 WO 2004080958 A3 WO2004080958 A3 WO 2004080958A3 US 2004006429 W US2004006429 W US 2004006429W WO 2004080958 A3 WO2004080958 A3 WO 2004080958A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tetrahydrotriazolopyrazines
- intermediates
- useful
- pyrazines
- triazolo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45274803P | 2003-03-07 | 2003-03-07 | |
| US60/452,748 | 2003-03-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2004080958A2 WO2004080958A2 (fr) | 2004-09-23 |
| WO2004080958A3 true WO2004080958A3 (fr) | 2004-12-23 |
Family
ID=32990678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2004/006429 Ceased WO2004080958A2 (fr) | 2003-03-07 | 2004-03-03 | Procede pour preparer des tetrahydrotriazolopyrazines et leurs produits intermediaires |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR043443A1 (fr) |
| TW (1) | TW200500368A (fr) |
| WO (1) | WO2004080958A2 (fr) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7132443B2 (en) | 2001-06-27 | 2006-11-07 | Smithklinebeecham Corporation | Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| US7470700B2 (en) | 2003-08-13 | 2008-12-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US7550590B2 (en) | 2003-03-25 | 2009-06-23 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US7842707B2 (en) | 2004-07-23 | 2010-11-30 | Nuada, Llc | Peptidase inhibitors |
| US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
| US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
| US8906901B2 (en) | 2005-09-14 | 2014-12-09 | Takeda Pharmaceutical Company Limited | Administration of dipeptidyl peptidase inhibitors |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7638638B2 (en) | 2003-05-14 | 2009-12-29 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| CN102675221A (zh) | 2005-09-16 | 2012-09-19 | 武田药品工业株式会社 | 用于制备嘧啶二酮衍生物的方法中的中间体 |
| WO2007112347A1 (fr) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Inhibiteurs de la dipeptidyl peptidase |
| TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| HRP20170712T1 (hr) | 2010-04-02 | 2017-07-28 | Ogeda Sa | Novi spojevi selektivnih antagonista nk-3 receptora, farmaceutski pripravak i postupci za uporabu kod poremećaja uzrokovanih nk-3 receptorima |
| US10065960B2 (en) | 2010-04-02 | 2018-09-04 | Ogeda Sa | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders |
| CN102372716A (zh) | 2010-08-09 | 2012-03-14 | 江苏恒瑞医药股份有限公司 | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 |
| CN101973997B (zh) * | 2010-09-30 | 2012-06-06 | 浙江大学 | 一种磷酸西他列汀侧链的制备方法 |
| WO2013001514A1 (fr) | 2011-06-29 | 2013-01-03 | Ranbaxy Laboratories Limited | Dispersions solides de sitagliptine et leurs procédés de préparation |
| EP2726483A1 (fr) | 2011-06-30 | 2014-05-07 | Ranbaxy Laboratories Limited | Nouveaux sels de sitagliptine |
| DK2763992T3 (en) | 2011-10-03 | 2016-04-25 | Euroscreen Sa | NOVEL CHIRAL N-acyl-5,6,7, (8-substituted) -tetrahydro [1,2,4] triazolo [4,3-a] pyrazines as selective NK-3 receptor antagonists, PHARMACEUTICAL COMPOSITION AND METHODS FOR THE use in the NK-3 receptor mediated diseases |
| WO2013084210A1 (fr) | 2011-12-08 | 2013-06-13 | Ranbaxy Laboratories Limited | Forme amorphe de sels de sitagliptine |
| SG11201702368PA (en) | 2014-09-25 | 2017-04-27 | Ogeda Sa | Novel chiral synthesis of n-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines |
| ES2638266T3 (es) | 2015-10-22 | 2017-10-19 | F.I.S.- Fabbrica Italiana Sintetici S.P.A. | Procedimiento mejorado para la preparación de triazol y una de sus sales |
| US10047094B1 (en) | 2017-02-10 | 2018-08-14 | F.I.S.—Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of triazole and salt thereof |
| EP3424927B1 (fr) | 2017-07-04 | 2019-04-17 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Procédé efficace de préparation de la sitagliptine au moyen d'une très efficace préparation d'acide 2,4,5-trifluorophenylacétique intermédiaire |
| BR112020013449A2 (pt) * | 2018-01-09 | 2020-12-01 | Jiangsu Hengrui Medicine Co., Ltd. | métodos de preparação de um inibidor de parp e de um intermediário do mesmo e método de purificação de um intermediário |
| EP3524605B1 (fr) | 2018-02-13 | 2019-11-27 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Nouveau procédé efficace pour la préparation de sitagliptine |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06128261A (ja) * | 1992-10-20 | 1994-05-10 | Toray Ind Inc | 3環性トリアゾロ誘導体の製造方法 |
| WO2003004498A1 (fr) * | 2001-07-06 | 2003-01-16 | Merck & Co., Inc. | Pyrazines beta-amino tetrahydroimidazo (1, 2-a) et pyrazines tetrahydrotrioazolo (4, 3-a) utilisees en tant qu'inhibiteurs de la dipeptidyl peptidase dans le traitement ou la prevention du diabete |
| WO2004021984A2 (fr) * | 2002-09-04 | 2004-03-18 | Bristol-Myers Squibb Company | Composes aromatiques heterocycliques utiles en tant que secretagogues d'hormone de croissance |
-
2004
- 2004-03-01 AR ARP040100646 patent/AR043443A1/es not_active Application Discontinuation
- 2004-03-03 WO PCT/US2004/006429 patent/WO2004080958A2/fr not_active Ceased
- 2004-03-05 TW TW093105894A patent/TW200500368A/zh unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06128261A (ja) * | 1992-10-20 | 1994-05-10 | Toray Ind Inc | 3環性トリアゾロ誘導体の製造方法 |
| WO2003004498A1 (fr) * | 2001-07-06 | 2003-01-16 | Merck & Co., Inc. | Pyrazines beta-amino tetrahydroimidazo (1, 2-a) et pyrazines tetrahydrotrioazolo (4, 3-a) utilisees en tant qu'inhibiteurs de la dipeptidyl peptidase dans le traitement ou la prevention du diabete |
| WO2004021984A2 (fr) * | 2002-09-04 | 2004-03-18 | Bristol-Myers Squibb Company | Composes aromatiques heterocycliques utiles en tant que secretagogues d'hormone de croissance |
Non-Patent Citations (3)
| Title |
|---|
| GARY A. MCCORT, JEAN CLAUDE PASCAL: "A rapid and Efficient Synthesis of Imidazo[1,2-a] and 1,2,4-Triazolo[4,3-a]-piperazine Carboxylic Acids", TETRAHEDRON LETTERS, vol. 33, no. 31, 1992, GB, pages 4443 - 4446, XP002295787 * |
| P.J. NELSON, K.T. POTTS: "1,2,4-Triazoles VI. The Synthesis of Some s-Triazolo[4,3-a]pyrazines", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 27, 1962, pages 3243 - 3248, XP002295788, ISSN: 0022-3263 * |
| PATENT ABSTRACTS OF JAPAN vol. 0184, no. 27 (C - 1235) 10 August 1994 (1994-08-10) * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7132443B2 (en) | 2001-06-27 | 2006-11-07 | Smithklinebeecham Corporation | Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| US7550590B2 (en) | 2003-03-25 | 2009-06-23 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US7470700B2 (en) | 2003-08-13 | 2008-12-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US7579357B2 (en) | 2003-08-13 | 2009-08-25 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US7842707B2 (en) | 2004-07-23 | 2010-11-30 | Nuada, Llc | Peptidase inhibitors |
| US8906901B2 (en) | 2005-09-14 | 2014-12-09 | Takeda Pharmaceutical Company Limited | Administration of dipeptidyl peptidase inhibitors |
| US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
| US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| TW200500368A (en) | 2005-01-01 |
| AR043443A1 (es) | 2005-07-27 |
| WO2004080958A2 (fr) | 2004-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004080958A3 (fr) | Procede pour preparer des tetrahydrotriazolopyrazines et leurs produits intermediaires | |
| PL392725A1 (pl) | Nowe związki pośrednie do syntezy związków triazolopirymidyny oraz sposób ich wytwarzania | |
| WO2004085661A3 (fr) | Procede de synthese de derives d'acides amines beta chiraux | |
| WO2003002553A3 (fr) | Fluoropyrrolidines inhibitrices de la dipeptidyl peptidase | |
| WO2004087650A3 (fr) | Procede et intermediaires pour la preparation d'inhibiteurs d'amide d'acide beta-amino de dipeptidyle peptidase-iv | |
| WO2002098865A3 (fr) | Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations de ces inhibiteurs | |
| WO2004052850A3 (fr) | Procedes et composes pour produire des inhibiteurs de la dipeptidyle-peptidase et leurs intermediaires | |
| WO2003002531A3 (fr) | Fluoropyrrolidines inhibitrices de la dipeptidyl peptidase | |
| WO2004052310A3 (fr) | Preparation de l'agent antiviral [1s-(1alpha, 3 alpha, 4 beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclo | |
| NO20050069L (no) | 8-[3-amino-piperidin-1-yl]-xantiner, fremstilling derav og anvendelse av disse som medikamenter | |
| AU2002316437A1 (en) | Pyrrolidines as dipeptidyl peptidase inhibitors | |
| WO2006116157A3 (fr) | Inhibiteurs de la dipeptidyl peptidase iv | |
| WO2005021536A3 (fr) | Nouveaux composes | |
| WO2005011581A3 (fr) | Hexahydrodiazepinones utilises en tant qu'inhibiteurs de la dipeptidyl peptidase iv pour le traitement ou la prevention du diabete | |
| TNSN05329A1 (en) | Phosphoric acid salt of a dipeptidyl peptidase -iv inhibitor | |
| MXPA05012362A (es) | Yodopirazolilcarboxanilidas. | |
| WO2005033099A3 (fr) | Nouveaux inhibiteurs de dipeptidylpeptidase iv, leurs procedes de preparation et compositions les contenant | |
| WO2001047928A3 (fr) | Nouveaux imidazo[1,3,5]triazinones et leur utilisation | |
| GEP20074017B (en) | Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b | |
| WO2005040171A8 (fr) | Derives de pyrazolo-pyrimidine et d'imidazo-pyrimidine | |
| TW200505923A (en) | Process to beta-ketoamide intermediates to dipeptidyl peptidase inhibitors | |
| AU2003272072A8 (en) | A process to prepare pioglitazone via several intermediates. | |
| WO2005068464A3 (fr) | Procede de preparation de tadalafil et ses intermediaires | |
| WO2007002308A3 (fr) | Procede de preparation de derives de piperazine azaindoleoxoacetique a substitution triazole et nouvelles formes de sels obtenues selon ce procede | |
| WO2006061215A3 (fr) | 2-alkyl-cycloalk(en)yl-carboxamides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| 122 | Ep: pct application non-entry in european phase |